A Multi-center, Randomized, Double-blind, Double-Dummy, Positive Parallel Controlled Study to Evaluate the Efficacy and Safety in Treatment of Mild-moderate Essential Hypertension
A Multi-center, Randomized, Double-blind, Double-Dummy, Positive Parallel Controlled Study to Evaluate the Efficacy and Safety in Treatment of Mild-moderate Essential Hypertension
The primary aim of the study is to assess the antihypertensive efficacy of SPH3127 in patients with mild to moderate essential hypertension.
Inclusion Criteria:
Exclusion Criteria:
Chongqing, Chongqing Municipality 404037, China
Wuhan, Hubei 430022, China
Baotou, Inner Mongolia 750306, China
Shanghai, Shanghai Municipality 200025, China
Hangzhou, Zhejiang 310003, China